Tu Anh Duong

*Teledermatology : design a healthcare service*. **TA. Duong**, J. Le Cardinal, JC. Bocquet. ICED 2013. *Emerging Telemedicine analysis of future Teledermatology application in France.* **TA. Duong**, R. Farel, J. Le Cardinal. MMEP 2003. Springer *Use Scenario to implement an innovative service Teledermatology*. **TA. Duong**, R. Farel, J. Le Cardinal. ASME 2014. *PSS for healthcare service engineering a user-centred approach using social networks.* **TA. Duong**, R. Farel, J. Le Cardinal, JC Bocquet.IcoRD 2015. Spronger

*Candidose cutanée diffuse révélatrice d’un lymphome T cutané : 2 cas.* **TA. Duong**, S. Ingen-Housz-Oro, A. Gaulier, A. Petit, L. Dubertret, M. Sigal-Grinberg.Ann Dermatol Venereol 2006 ; 133 : 566-70. *Document iconographique : Syndrome de Cronkhite et Canada*. **TA. Duong**, F.Marrache, M. Nachury , L. Dubertret , M. Lémann, M. Viguier. Ann Dermatol Venereol 2007 ; 134 :709-10. *A new cause of “gloves and socks” syndrome: Chicken pox*. **TA. Duong**, E. Poszepczynska-Guigné, N. Poulalhon, D. Challine, J. Revuz, M. Bagot, P. Wolkenstein., JEADV 2008; 23:329-30. *First fixed drug eruption due to Teicoplanin with a peri-oral distribution*. **TA. Duong**, D. Hamel, S. Benlahrech, KH. Le Quan Sang, H. Sauvé-Martin, JC. Roujeau, Y. de Prost, S. Hadj-Rabia. JEADV 2009, 23 : 1107. *Toxidermies*. **TA. Duong**, L. Valeyrie-Allanore. EMC, 2009. *Efalizumab-induced bullous pemphigoid.* **TA. Duong**, V. Buffard, N. Ortonne, C. André, C. Chauvel, J. Revuz , M. Bagot, JC. Roujeau *.* Journal of the american academy of dermatology 2010; *62:161-2.* *Cutaneous Richter syndrome; prognosis, clinical, histological, immuno-histological patterns: Report of 4 cases and review.* **TA. Duong**, N. Auffret, F. Grange, O. Hermine, S.Aractingi, C. Bodemer, N. Brousse , S. Fraitag. Dermatology 2010; 220: 226-33. *Evolving pattern with age of cutaneous signs in neurofibromatosis type 1: a cross-sectional study of 728 patients.* **TA. Duong**, S. Bastuji-Garin,L. Valeyrie-Allanore, E. Sbidian, S. Ferkal, P. Wolkenstein.. Dermatology 2011;222: 269-73. *Mortality associated with neurofibromatosis 1: a cohort study of 1895 patients in 1980-2006 in france.***TA. Duong** ,E. Sbidian,L. Valeyrie-Allanore,C. Vialette,S. Ferkal,S. Hadj-Rabia, C. Glorion,S. Lyonnet, M. Zerah, I. Kemlin, D. Rodriguez, S. Bastuji-Garin, P. Wolkenstein. Orphanet J Rare Dis 2011; 4; 6:18. *Toxidermies aux nouvelles thérapeutiques.* **TA. Duong**, L. Valeyrie-Allanore, O. Chosidow. La revue de l’internat 2012. *Levetiracetam: a possible new inducer of toxic epidermal necrolysis and Stevens-Johnson syndrome based on two cases.***TA. Duong**, C. Haddad, L. Valeyrie-Allanore, E. Sbidian, P.Wolkenstein, O. Chosidow. JAMA Dermatol 2013;149: 113-5. *Improvement of skin diseases diagnosis and management in the emergency room thanks to mobile phone real time teleexpertise.* **TA. Duong**, F. Cordoliani, E. Bourrat, C. Juillard, S. Regnier c, L. de Pontual, C. Leroy, S. Gallula, C. Aparicio, N. Legendre, M Bagot, F Guibal. Archives of Dermatology 2014;150: 743-47. *[Stevens-Johnson syndrome and toxic epidermal necrolysis: follow-up of pulmonary function after remission.](http://www.ncbi.nlm.nih.gov/pubmed/25496398)* **TA. Duong**, N de Prost , O. Ingen-Housz-Oro, AS. Carrié, F. Zerah, L. Valeyrie-Allanore, M. Bagot, O. Chosidow, JC. Roujeau, P. Wolkenstein, B. Maitre. Br J Dermatol 2015 ; 172: 400-5. *[Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Ear, Nose, and Throat Description at Acute Stage and After Remission.](http://www.ncbi.nlm.nih.gov/pubmed/25671761)* E. Bequignon\*, TA **Duong\***, ESbidian, L. Valeyrie-Allanore, S. Ingen-Housz-Oro, V. Chatelin, A. Coste, P. Wolkenstein\*, O. Chosidow\*, JF Papon\*. JAMA Dermatol 2015, in press.